Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Longmate, J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 25 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Margolin, K; Synold, T; Longmate, J; Doroshow, JH
      Methodologic guidelines for the design of high-dose chemotherapy regimens

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    2. Somlo, G; Chow, W; Hamasaki, V; Leong, L; Margolin, K; Morgan, R; Sniecinski, I; Frankel, P; Reardon, D; Longmate, J; Raschko, J; Shibata, S; O'Donnell, M; Smith, E; Tetef, M; Forman, S; Yen, Y; Molina, A; Doroshow, JH
      Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    3. Lara, PN; Gandara, DR; Longmate, J; Gumerlock, PH; Martin, DHML; Edelman, J; Gandour-Edwards, R; Mack, PC; Israel, V; Raschko, J; Frankel, P; Perez, EA; Lenz, HJ; Doroshow, JH
      Activity of high-dose toremifene plus cisplatin in platinum-treated nonsmall-cell lung cancer: a phase II California Cancer Consortium Trial

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    4. Morgan, RJ; Synold, T; Carr, BI; Doroshow, JH; Womack, EP; Shibata, S; Somlo, G; Raschko, J; Leong, L; McNamara, M; Chow, W; Tetef, M; Margolin, K; Akman, S; Longmate, J
      Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    5. Morgan, RJ; Doroshow, JH; Leong, L; Schriber, J; Shibata, S; Forman, S; Hamasaki, V; Margolin, K; Somlo, G; Alvarnas, J; McNamara, M; Longmate, J; Raschko, J; Chow, W; Vasilev, S; McGonigle, K; Yen, Y
      Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer

      BONE MARROW TRANSPLANTATION
    6. Ran, RL; Vora, N; Yang, F; Longmate, J; Wang, W; Sun, H; Li, JR; Weiss, L; Staud, C; McDougall, JA; Chou, CK
      Variations of dose and electrode spacing for rat breast cancer electrochemical treatment

      BIOELECTROMAGNETICS
    7. Margolin, K; Longmate, J; Synold, TW; Gandara, DR; Weber, J; Gonzalez, R; Johansen, MJ; Newman, R; Baratta, T; Doroshow, JH
      Dolastatin-10 in metastatic melanoma: A phase II and pharmokinetic trial of the california cancer consortium

      INVESTIGATIONAL NEW DRUGS
    8. Longmate, J; York, J; La Rosa, C; Krishnan, R; Zhang, M; Senitzer, D; Diamond, DJ
      Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes

      IMMUNOGENETICS
    9. Han, X; Lundberg, P; Tanamachi, B; Openshaw, H; Longmate, J; Cantin, E
      Gender influences herpes simplex virus type 1 infection in normal and gamma interferon-mutant mice

      JOURNAL OF VIROLOGY
    10. Han, X; Lundberg, P; Tanamachi, B; Openshaw, H; Longmate, J; Cantin, E
      Gender influences herpes simplex virus type 1 infection in normal and gamma interferon-mutant mice (vol 75, pg 3048, 2001)

      JOURNAL OF VIROLOGY
    11. Villacres, MC; Lacey, SF; La Rosa, C; Krishnan, R; Auge, C; Longmate, J; Zaia, JA; Leedom, JM; Diamond, DJ
      Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8(+) T cell subsets as a strong adaptive immune response to cytomegalovirus

      JOURNAL OF INFECTIOUS DISEASES
    12. Somlo, G; Doroshow, JH; Synold, T; Longmate, J; Reardon, D; Chow, W; Forman, SJ; Leong, LA; Margolin, KA; Morgan, RJ; Raschko, JW; Shibata, SI; Tetef, ML; Yen, Y; Kogut, N; Schriber, J; Alvarnas, J
      High-dose paclitaxel in combination with doxorubicin, cyclophosphamide andperipheral blood progenitor cell rescue in patients with high-risk primaryand responding metastatic breast carcinoma: toxicity profile, relationshipto paclitaxel pharmacokinetics and short-term outcome

      BRITISH JOURNAL OF CANCER
    13. BenMohamed, L; Krishnan, R; Longmate, J; Auge, C; Low, L; Primus, J; Diamond, DJ
      Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: Dependence on HLA class II restricted T-H response

      HUMAN IMMUNOLOGY
    14. Morgan, RJ; Braly, P; Leong, L; Shibata, S; Margolin, K; Somlo, G; McNamara, M; Longmate, J; Schinke, S; Raschko, J; Nagasawa, S; Kogut, N; Najera, L; Johnson, D; Doroshow, JH
      Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracilin previously treated patients with advanced ovarian cancer: Long-term follow-up

      GYNECOLOGIC ONCOLOGY
    15. Abdel-Mageed, A; Graham-Pole, J; Del Rosario, MLU; Longmate, J; Ochoa, S; Amylon, M; Elfenbein, GJ; Janiec, J; Jansen, J; Lazarus, HM
      Comparison of two doses of intravenous immunoglobulin after allogeneic bone marrow transplants

      BONE MARROW TRANSPLANTATION
    16. Morgan, RJ; Braly, P; Cecchi, G; Leong, L; Shibata, S; Margolin, K; Somlo, G; McNamara, M; Longmate, J; Schinke, S; Raschko, J; Nagasawa, S; Kogut, N; Parker, P; Stein, A; Cho, J; Smith, E; Coluzzi, P; Najera, L; Johnson, D; Womack, E; Doroshow, JH
      Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up

      GYNECOLOGIC ONCOLOGY
    17. Somlo, G; Sniecinski, I; ter Veer, A; Longmate, J; Knutson, G; Vuk-Pavlovic, S; Bhatia, R; Chow, W; Leong, L; Morgan, R; Margolin, K; Raschko, J; Shibata, S; Tetef, M; Yen, Y; Forman, S; Jones, D; Ashby, M; Fyfe, G; Hellmann, S; Doroshow, JH
      Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy

      BLOOD
    18. SODERHOLM KJM; LONGMATE J; GARCEA J; MUKHERJEE R
      FILLER LEACHABILITY OF COMPOSITES STORED IN DISTILLED WATER OR ARTIFICIAL SALIVA

      Journal of dental research
    19. SODERHOLM KJM; LAMBRECHTS P; SARRETT D; WILLEMS G; LONGMATE J; LABELLA R; YILDIR E
      CLINICAL WEAR PERFORMANCE OF 8 EXPERIMENTAL DENTAL COMPOSITES AFTER 3YEARS

      Journal of dental research
    20. MORGAN RJ; NEWMAN EM; DOROSHOW JH; MCGONIGLE K; MARGOLIN K; RASCHKO J; CHOW W; SOMLO G; LEONG L; TETEF M; SHIBATA S; HAMASAKI V; CARROLL M; VASILEV S; AKMAN S; COLUZZI P; WAGMAN L; LONGMATE J; PAZ B; YEN Y; KLEVECZ R
      PHASE-I TRIAL OF INTRAPERITONEAL IODODEOXYURIDINE WITH AND WITHOUT INTRAVENOUS HIGH-DOSE FOLINIC ACID IN THE TREATMENT OF ADVANCED MALIGNANCIES PRIMARILY CONFINED TO THE PERITONEAL-CAVITY - FLOW CYTOMETRIC ANDPHARMACOKINETIC ANALYSIS

      Cancer research
    21. WAKELAND E; MOREL L; ACHEY K; YUI M; LONGMATE J
      SPEED CONGENICS - A CLASSIC TECHNIQUE IN THE FAST LANE (RELATIVELY SPEAKING)

      Immunology today
    22. LARSON GP; ZHANG G; DING S; FOLDENAUER K; UDAR N; GATTI RA; NEUBERG D; LUNETTA K; LONGMATE J; FLANAGAN S; KRONTIRIS TG
      AN ALLELIC VARIANT AT THE ATM LOCUS IS IMPLICATED IN BREAST-CANCER SUSCEPTIBILITY

      American journal of human genetics
    23. SODERHOLM KJM; MUKHERJEE R; LONGMATE J
      FILLER LEACHABILITY OF COMPOSITES STORED IN DISTILLED WATER OR ARTIFICIAL SALIVA

      Journal of dental research
    24. ROULET JF; SODERHOLM KJM; LONGMATE J
      EFFECTS OF TREATMENT AND STORAGE-CONDITIONS ON CERAMIC COMPOSITE BONDSTRENGTH

      Journal of dental research
    25. SODERHOLM KJM; MUKHERJEE R; LONGMATE J
      FILLER LEACHABILITY OF COMPOSITES STORED IN DISTILLED WATER OR ARTIFICIAL SALIVA

      Journal of dental research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/08/20 alle ore 05:55:33